AgingResearch.NewsJoin free

Amalaki rasayana

Intervention

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: Indian Council of Medical Research
  • Humans1

Outcomes

2

LGALS3

downin rats1

1 study

  1. Amalaki rasayana inhibits LGALS3 in rats.

    “by inhibiting full-length galectin-3 secretion through phosphorylation-dependent mechanisms and promotion of intracellular retention”

    Animalsin rat models of BA and PO-CH

    Galectin-3 C-epitope, ANP, PPIA, and albumin function as drug-responsive panel biomarkers and therapeutic targets in aging and pressure overload-induced cardiac hypertrophy

    bioRxiv (Cold Spring Harbor Laboratory)3 Jun 2025Preprint

More on LGALS3

GALECTIN-3 C-epitope

downin rats1

1 study

  1. Amalaki rasayana decreases GALECTIN-3 C-epitope in rats.

    “Treatment with AR and its bioactive component gallic acid (GA) suppressed extracellular galectin-3 C-epitope oligomer accumulation”

    Animalsin rat models of BA and PO-CH

    Galectin-3 C-epitope, ANP, PPIA, and albumin function as drug-responsive panel biomarkers and therapeutic targets in aging and pressure overload-induced cardiac hypertrophy

    bioRxiv (Cold Spring Harbor Laboratory)3 Jun 2025Preprint

More on GALECTIN-3 C-epitope

Latest

Related